NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Medexus Pharmaceuticals Inc (OTCQX: MEDXF)
MEDXF Technical Analysis
1.5
As on 12th Nov 2024 MEDXF STOCK Price closed @ 1.38 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.55 & Buy for SHORT-TERM with Stoploss of 1.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MEDXFSTOCK Price
Open | 1.38 | Change | Price | % |
High | 1.41 | 1 Day | -0.09 | -6.12 |
Low | 1.27 | 1 Week | -0.32 | -18.82 |
Close | 1.38 | 1 Month | -0.47 | -25.41 |
Volume | 14200 | 1 Year | 0.47 | 51.65 |
52 Week High 2.53 | 52 Week Low 0.86 |
OTCQX USA Most Active Stocks
KRRGF | 4.83 | 2.33% |
FCUUF | 0.52 | -20.00% |
FNGR | 1.07 | -46.50% |
GBTC | 76.47 | 0.20% |
ETHE | 32.63 | 1.21% |
ZNOG | 0.07 | 0.00% |
CURLF | 2.04 | 22.89% |
VRNOF | 1.90 | 24.18% |
AOTVF | 0.14 | -6.67% |
CRLBF | 1.26 | 21.15% |
OTCQX USA Top Gainers Stocks
OTCQX USA Top Losers Stocks
MEDXF Daily Charts |
MEDXF Intraday Charts |
Whats New @ Bazaartrend |
MEDXF Free Analysis |
|
MEDXF Important Levels Intraday
RESISTANCE | 1.65 |
RESISTANCE | 1.56 |
RESISTANCE | 1.51 |
RESISTANCE | 1.46 |
SUPPORT | 1.30 |
SUPPORT | 1.25 |
SUPPORT | 1.20 |
SUPPORT | 1.11 |
MEDXF Forecast December 2024
4th UP Forecast | 2.73 |
3rd UP Forecast | 2.3 |
2nd UP Forecast | 2.03 |
1st UP Forecast | 1.76 |
1st DOWN Forecast | 1 |
2nd DOWN Forecast | 0.73 |
3rd DOWN Forecast | 0.46 |
4th DOWN Forecast | 0.03 |
MEDXF Weekly Forecast
4th UP Forecast | 1.61 |
3rd UP Forecast | 1.54 |
2nd UP Forecast | 1.49 |
1st UP Forecast | 1.45 |
1st DOWN Forecast | 1.31 |
2nd DOWN Forecast | 1.27 |
3rd DOWN Forecast | 1.22 |
4th DOWN Forecast | 1.15 |
MEDXF Forecast2024
4th UP Forecast | 4.69 |
3rd UP Forecast | 3.63 |
2nd UP Forecast | 2.97 |
1st UP Forecast | 2.32 |
1st DOWN Forecast | 0.44 |
2nd DOWN Forecast | -0.21 |
3rd DOWN Forecast | -0.87 |
4th DOWN Forecast | -1.93 |
Medexus Pharmaceuticals Inc ( OTCQX USA Symbol : MEDXF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MEDXF Other Details
Segment | EQ | |
Market Capital | 50531564.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
MEDXF Address
MEDXF Latest News
MEDXF Business Profile
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis psoriasis, and juvenile idiopathic arthritis; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also include Treosulfan, a conditioning agent used prior to stem cell transplantation; and Triamcinolone Hexacetonide for intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Bolton, Canada. Address: 35 Nixon Road, Bolton, ON, Canada, L7E 1K1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service